TY - JOUR AU - DiMasi, J. A. AU - Hansen, R. W. AU - Grabowski, H. G. PY - 2003 DA - 2003// TI - The price of innovation: new estimates of drug development costs. JO - Journal of Health Economics VL - 22 UR - https://doi.org/10.1016/S0167-6296(02)00126-1 DO - 10.1016/S0167-6296(02)00126-1 ID - DiMasi2003 ER - TY - JOUR AU - Kola, I. AU - Landis, J. PY - 2004 DA - 2004// TI - Can the pharmaceutical industry reduce attrition rates? JO - Nature Reviews Drug Discovery VL - 3 UR - https://doi.org/10.1038/nrd1470 DO - 10.1038/nrd1470 ID - Kola2004 ER - TY - JOUR AU - Woosley, R. L. PY - 2007 DA - 2007// TI - Drug development and the FDA’s critical path initiative. JO - Clinical Pharmacology and Therapeutics VL - 81 UR - https://doi.org/10.1038/sj.clpt.6100014 DO - 10.1038/sj.clpt.6100014 ID - Woosley2007 ER - TY - JOUR AU - Veit, M. PY - 2007 DA - 2007// TI - New strategies for drug development JO - Berl. Munch. Tierarztl. Wochenschr. VL - 117 ID - Veit2007 ER - TY - JOUR AU - D'Andrea, G. PY - 2005 DA - 2005// TI - A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-06-2111 DO - 10.1182/blood-2004-06-2111 ID - D'Andrea2005 ER - TY - JOUR AU - Kirchheiner, J. B. PY - 2005 DA - 2005// TI - Clinical consequences of cytochrome P450 2C9 polymorphisms. JO - Clin. Pharmacol. Ther. VL - 77 UR - https://doi.org/10.1016/j.clpt.2004.08.009 DO - 10.1016/j.clpt.2004.08.009 ID - Kirchheiner2005 ER - TY - JOUR AU - Badagnani, I. PY - 2005 DA - 2005// TI - Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J. Pharmacol. JO - Exp. Ther. VL - 318 UR - https://doi.org/10.1124/jpet.106.104364 DO - 10.1124/jpet.106.104364 ID - Badagnani2005 ER - TY - JOUR AU - Hung, S. I. PY - 2006 DA - 2006// TI - Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions JO - Pharmacogenet. Genom VL - 16 UR - https://doi.org/10.1097/01.fpc.0000199500.46842.4a DO - 10.1097/01.fpc.0000199500.46842.4a ID - Hung2006 ER - TY - JOUR AU - Cleary, J. D. AU - Taylor, J. W. AU - Chapman, S. W. PY - 1992 DA - 1992// TI - Itraconazole in antifungal therapy. JO - Ann Pharmacother VL - 26 ID - Cleary1992 ER - TY - JOUR AU - Yamazaki, M. AU - Nishigaki, R. AU - Suzuki, H. AU - Sugiyama, Y. PY - 1995 DA - 1995// TI - [Kinetic analysis of hepatobiliary transport of drugs, importance of carrier-mediated transport]. JO - Yakugaku Zasshi VL - 115 ID - Yamazaki1995 ER - TY - JOUR AU - Okuda, H. AU - Nishiyama, T. AU - Ogura, K. AU - Nagayama, S. AU - Ikeda, K. AU - Yamaguchi, S. AU - Nakamura, Y. AU - Kawaguchi, Y. AU - Watabe, T. PY - 1997 DA - 1997// TI - Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. JO - Drug Metab Dispos VL - 25 ID - Okuda1997 ER - TY - JOUR AU - Lalonde, R. L. AU - Hutmacher, M. M. AU - Ewy, W. AU - Nichols, D. J. AU - Milligan, P. A. AU - Corrigan, B. W. AU - Lockwood, P. A. AU - Marshall, S. A. AU - Benincosa, L. J. AU - Tensfeldt, T. G. AU - Parivar, K. AU - Amantea, M. AU - Glue, P. AU - Koide, H. AU - Miller, R. PY - 2007 DA - 2007// TI - Model-based drug development. JO - Clin Pharmacol Ther VL - 82 UR - https://doi.org/10.1038/sj.clpt.6100235 DO - 10.1038/sj.clpt.6100235 ID - Lalonde2007 ER - TY - JOUR AU - Chang, M. K. S. AU - Bull, J. AU - Chiu, Y. Y. AU - Wang, W. AU - Wakeford, C. AU - McCarthy, K. PY - 2007 DA - 2007// TI - Innovative approaches in drug development. JO - J Biopharm Stat VL - 17 UR - https://doi.org/10.1080/10543400701513926 DO - 10.1080/10543400701513926 ID - Chang2007 ER - TY - JOUR AU - RT, O. N. PY - 2006 DA - 2006// TI - FDA's critical path initiative: a perspective on contributions of biostatistics. JO - Biom J VL - 48 UR - https://doi.org/10.1002/bimj.200510237 DO - 10.1002/bimj.200510237 ID - RT2006 ER - TY - JOUR AU - Chien, J. Y. AU - Heathman, M. A. AU - de Alwis, D. P. AU - Sinha, V. PY - 2005 DA - 2005// TI - Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation. JO - The AAPS Journal VL - 7 UR - https://doi.org/10.1208/aapsj070355 DO - 10.1208/aapsj070355 ID - Chien2005 ER - TY - CHAP AU - Rowland, M. AU - Tozer, T. N. PY - 1995 DA - 1995// BT - Clinical Pharmacokinetics Concept and Applications. PB - Wilkins CY - USA ID - Rowland1995 ER - TY - CHAP AU - Davidian, M. AU - Giltinan, D. M. PY - 1995 DA - 1995// BT - Nonlinear models for repeated measurment data. PB - Chapman and Hall CY - USA ID - Davidian1995 ER - TY - JOUR AU - Wakefield, J. C. AU - Rahman, N. PY - 2000 DA - 2000// TI - The combination of population pharmacokinetic studies. JO - Biometrics VL - 56 UR - https://doi.org/10.1111/j.0006-341X.2000.00263.x DO - 10.1111/j.0006-341X.2000.00263.x ID - Wakefield2000 ER - TY - JOUR AU - Lopes, H. F. AU - Muller, P. AU - Rosner, G. L. PY - 2003 DA - 2003// TI - Bayesian meta-analysis for longitudinal data models using multivariate mixture priors. JO - Biometrics VL - 59 UR - https://doi.org/10.1111/1541-0420.00008 DO - 10.1111/1541-0420.00008 ID - Lopes2003 ER - TY - JOUR AU - Li, L. AU - Yu, M. AU - Chin, R. AU - Lucksiri, A. AU - Flockhart, D. AU - Hall, S. PY - 2007 DA - 2007// TI - Drug-Drug Interaction Prediction: A Bayesian Meta-Analysis Approach. JO - Statistis in Medicine VL - 26 UR - https://doi.org/10.1002/sim.2837 DO - 10.1002/sim.2837 ID - Li2007 ER - TY - JOUR AU - Yu, M. PY - 2008 DA - 2008// TI - A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction. JO - J Biopharm Stat VL - 18 UR - https://doi.org/10.1080/10543400802369004 DO - 10.1080/10543400802369004 ID - Yu2008 ER - TY - JOUR AU - Wolfinger, R. D. PY - 1997 DA - 1997// TI - Two Taylor-series approximations methods for nonlinear mixed models. JO - Journal of Computational Statistics and Data Analysis VL - 25 UR - https://doi.org/10.1016/S0167-9473(97)00012-1 DO - 10.1016/S0167-9473(97)00012-1 ID - Wolfinger1997 ER - TY - JOUR AU - Wolfinger, R. AU - O'Connell, M. PY - 1993 DA - 1993// TI - Generalized linear mixed models: a pseudo-likelihood approach. JO - Journal of statistical Computation and Simulation VL - 48 UR - https://doi.org/10.1080/00949659308811554 DO - 10.1080/00949659308811554 ID - Wolfinger1993 ER - TY - JOUR AU - Lindstrom, M. L. AU - Bates, D. M. PY - 1990 DA - 1990// TI - Nonlinear mixed effects models for repeated measures data. JO - Biometrics VL - 46 UR - https://doi.org/10.2307/2532087 DO - 10.2307/2532087 ID - Lindstrom1990 ER - TY - JOUR AU - Wolfinger, R. D. PY - 1993 DA - 1993// TI - Laplace's Approximation for Nonlinear Mixed Models. JO - Biometrika VL - 80 UR - https://doi.org/10.1093/biomet/80.4.791 DO - 10.1093/biomet/80.4.791 ID - Wolfinger1993 ER - TY - CHAP AU - Westfall, P. AU - Hochberg, Y. AU - Wolfinger, R. D. AU - Rorn, D. AU - Tobias, R. D. PY - 1999 DA - 1999// BT - Multiple comparisons and Multiple Tests. ID - Westfall1999 ER - TY - JOUR AU - Vonesh, E. F. PY - 1996 DA - 1996// TI - A Note on Laplace's Approximation in Nonlinear Mixed Effects Models. JO - Biometrika VL - 83 UR - https://doi.org/10.1093/biomet/83.2.447 DO - 10.1093/biomet/83.2.447 ID - Vonesh1996 ER -